FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282930742> ?p ?o ?g. }

• W4282930742 endingPage "2148" @default.
• W4282930742 startingPage "2148" @default.
• W4282930742 abstract "Abstract Pancreatic ductal adenocarcinoma (PDAC) is a dismal disease, with the majority of patients diagnosed at an advanced stage. Comprehensive genomic analysis identified the homologous recombination deficiency (HRD) subgroup which is predominantly enriched in patients harboring germline BRCA1/2 mutations (glBRCA) and presents ~7% and up to 15% in selected high-risk populations. Tumors with HRD are susceptible to DNA-damaging agents and PARP inhibition. However, not all patients demonstrate a similar response, and a spectrum is observed. We analyzed the clinical outcome of ninety-one glBRCA PDAC patients treated at Sheba Medical Center. We identify three main subgroups of response spanning from ~25% patients refractory to first line platinum agents and ~9% patients with durable long-term response with no evidence of disease for over three years. The majority of the patients display a prolonged response to platinum and PARPi maintenance (&gt;24 months) followed by acquired resistance. We generated patient derived xenograft (PDX) models and an ex-vivo culture system (EVOC) from naïve to treatment tissue and at clinical resistance. In vivo efficacy to platinum agents and PARPi demonstrates that these models recapitulate the specific clinical spectrum of response. We demonstrate the utility of both pre-clinical models in their ability to predict response to platinum-based agents and PARPi, with EVOC having a potential to assist in medical decisions while treating the patient. Whole genome sequencing of the tumors revealed that BRCA monoallelic tumors are associated with innate resistance while biallelic tumors reflect sensitivity to platinum agents and PARPi. In the acquired resistance models, the main identified mechanism of resistance was due to reversion mutations in 4/6 of samples. Whole genome analysis demonstrates high mutational and neo-antigen load in majority of the glBRCA tumors. In a preliminary study, we show the efficacy of anti PD1 in a novel humanized glBRCA PDAC PDX model. This extensive preclinical and clinical collection of BRCA associated PDAC, enables further understanding and investigation of this unique subtype in aim to develop alternative treatments to overcome resistance. Citation Format: Talia Golan, Chani Stossel, Maria Raitses-Gurevitch, Dikla Atias, Tamar Beller, Steven Gallinger, Raanan Berger. Pre-clinical models recapitulating the spectrum of response of BRCA associated pancreatic cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 2148." @default.
• W4282930742 created "2022-06-16" @default.
• W4282930742 creator A5016377624 @default.
• W4282930742 creator A5025348994 @default.
• W4282930742 creator A5031683073 @default.
• W4282930742 creator A5062199973 @default.
• W4282930742 creator A5072940785 @default.
• W4282930742 creator A5077022619 @default.
• W4282930742 creator A5078820101 @default.
• W4282930742 date "2022-06-15" @default.
• W4282930742 modified "2023-10-07" @default.
• W4282930742 title "Abstract 2148: Pre-clinical models recapitulating the spectrum of response of BRCA associated pancreatic cancer" @default.
• W4282930742 doi "https://doi.org/10.1158/1538-7445.am2022-2148" @default.
• W4282930742 hasPublicationYear "2022" @default.
• W4282930742 type Work @default.
• W4282930742 citedByCount "0" @default.
• W4282930742 crossrefType "journal-article" @default.
• W4282930742 hasAuthorship W4282930742A5016377624 @default.
• W4282930742 hasAuthorship W4282930742A5025348994 @default.
• W4282930742 hasAuthorship W4282930742A5031683073 @default.
• W4282930742 hasAuthorship W4282930742A5062199973 @default.
• W4282930742 hasAuthorship W4282930742A5072940785 @default.
• W4282930742 hasAuthorship W4282930742A5077022619 @default.
• W4282930742 hasAuthorship W4282930742A5078820101 @default.
• W4282930742 hasConcept C104317684 @default.
• W4282930742 hasConcept C121608353 @default.
• W4282930742 hasConcept C126322002 @default.
• W4282930742 hasConcept C143998085 @default.
• W4282930742 hasConcept C182979987 @default.
• W4282930742 hasConcept C2779134260 @default.
• W4282930742 hasConcept C2779138821 @default.
• W4282930742 hasConcept C2780210213 @default.
• W4282930742 hasConcept C502942594 @default.
• W4282930742 hasConcept C535046627 @default.
• W4282930742 hasConcept C54355233 @default.
• W4282930742 hasConcept C71924100 @default.
• W4282930742 hasConcept C82381507 @default.
• W4282930742 hasConcept C86803240 @default.
• W4282930742 hasConceptScore W4282930742C104317684 @default.
• W4282930742 hasConceptScore W4282930742C121608353 @default.
• W4282930742 hasConceptScore W4282930742C126322002 @default.
• W4282930742 hasConceptScore W4282930742C143998085 @default.
• W4282930742 hasConceptScore W4282930742C182979987 @default.
• W4282930742 hasConceptScore W4282930742C2779134260 @default.
• W4282930742 hasConceptScore W4282930742C2779138821 @default.
• W4282930742 hasConceptScore W4282930742C2780210213 @default.
• W4282930742 hasConceptScore W4282930742C502942594 @default.
• W4282930742 hasConceptScore W4282930742C535046627 @default.
• W4282930742 hasConceptScore W4282930742C54355233 @default.
• W4282930742 hasConceptScore W4282930742C71924100 @default.
• W4282930742 hasConceptScore W4282930742C82381507 @default.
• W4282930742 hasConceptScore W4282930742C86803240 @default.
• W4282930742 hasIssue "12_Supplement" @default.
• W4282930742 hasLocation W42829307421 @default.
• W4282930742 hasOpenAccess W4282930742 @default.
• W4282930742 hasPrimaryLocation W42829307421 @default.
• W4282930742 hasRelatedWork W2621624083 @default.
• W4282930742 hasRelatedWork W4362493060 @default.
• W4282930742 hasRelatedWork W4362495229 @default.
• W4282930742 hasRelatedWork W4380590578 @default.
• W4282930742 hasRelatedWork W4380590624 @default.
• W4282930742 hasRelatedWork W4380590638 @default.
• W4282930742 hasRelatedWork W4381955958 @default.
• W4282930742 hasRelatedWork W4385446207 @default.
• W4282930742 hasRelatedWork W4385457923 @default.
• W4282930742 hasRelatedWork W4385460871 @default.
• W4282930742 hasVolume "82" @default.
• W4282930742 isParatext "false" @default.
• W4282930742 isRetracted "false" @default.
• W4282930742 workType "article" @default.